The Truth About Softgels: Phthalate-Free, Powered by Glycerin and Sorbitol
January 9, 2026
Catalent offers clarification after recent discussions raised concerns around softgels, phthalates and potential health risks
3 min read
False
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
All the latest Medicine Maker articles.
December 29, 2025
Agentic AI combined with human control points creates a new paradigm for accelerating documentation while maintaining regulatory integrity.
5 min read
December 22, 2025
The pandemic catalyzed a transformation in antiviral R&D. From better data to open collaboration, Tetiana Matviyuk of Enamine describes how the landscape has evolved.
3 min read
December 18, 2025
NAMs aren’t just a scientific upgrade, but a moral and practical necessity. The tools are ready. The question is: does the industry have the will to use them?
3 min read
December 17, 2025
New clinical results outline patient responses to a donor-derived, gene-edited cell therapy in relapsed and refractory T-cell leukemia
2 min read
December 17, 2025
The promise of cell and gene therapy is boundless, but data silos are holding it back. Standardization, interoperability, and collaboration can move data as freely as science itself.
5 min read
December 16, 2025
Our latest news roundup reports on the oversubscribed financing for Cellular Origins, FDA approval for Amgen, CAR-T cell therapy outcomes, and more
5 min read
December 15, 2025
Clinical trials are becoming longer, costlier and more complex, but a growing number of sponsors are finding agility in a hybrid approach.
4 min read
December 12, 2025
Why the industry should open its eyes to the benefits of microneedle array patches for drug delivery.
5 min read
December 11, 2025
Borrowing strategy from ancient Greece, Trogenix hides its therapeutic warriors inside tumor cells. CEO Ken Macnamara discusses how.
5 min read
December 11, 2025
The UK’s pharma manufacturing base still has potential, but only if companies modernize operations, boost efficiency, and show global investors that the UK can compete on cost and capability.
6 min read
False